Pfizer Inc. (PFE): Price and Financial Metrics

PFE POWR Grades

• Growth is the dimension where PFE ranks best; there it ranks ahead of 97.14% of US stocks.
• PFE's strongest trending metric is Growth; it's been moving up over the last 163 days.
• PFE's current lowest rank is in the Momentum metric (where it is better than 12.47% of US stocks).

PFE Stock Summary

• PFE has a higher market value than 99.5% of US stocks; more precisely, its current market capitalization is $303,375,439,622.
• PFE's went public 36.08 years ago, making it older than 92.74% of listed US stocks we're tracking.
• With a year-over-year growth in debt of -36.85%, Pfizer Inc's debt growth rate surpasses merely 13.3% of about US stocks.
• Stocks that are quantitatively similar to PFE, based on their financial statements, market capitalization, and price volatility, are ASML, XOM, DIS, TM, and KO.
• Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to www.pfizer.com.

PFE Valuation Summary

• PFE's price/sales ratio is 5; this is 55.95% lower than that of the median Healthcare stock.
• PFE's price/sales ratio has moved down 2.9 over the prior 243 months.
• Over the past 243 months, PFE's price/earnings ratio has gone down 17.6.

Below are key valuation metrics over time for PFE.

PFE Growth Metrics

Its year over year net income to common stockholders growth rate is now at -29.76%.
• Its 3 year revenue growth rate is now at 5.62%.
• Its 3 year net income to common stockholders growth rate is now at 51.01%.

Over the past 49 months, PFE's revenue has gone up $11,129,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	63,600	32,291	19,180
2021-06-30	51,637	23,552	13,228
2021-03-31	44,461	15,808	11,091
2020-12-31	41,908	14,403	9,616
2020-09-30	48,648	12,547	8,685
2020-06-30	49,197	14,967	14,171

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
• PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
• XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.